Viral delivery of neoantigens
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- GRITSTONE BIO INC
- Publication Date
- 2019-12-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Cross references to related applications
[0002] This application requires U.S. Provisional Application No. 62 / 425,996 filed on November 23, 2016; U.S. Provisional Application No. 62 / 435,266 filed on December 16, 2016; U.S. Provisional Application No. 62 / 435,266 filed on May 8, 2017 Application No. 62 / 503,196; and U.S. Provisional Application No. 62 / 523,212 filed on June 21, 2017, each of which is incorporated herein by reference in its entirety.
[0003] Sequence Listing
[0004] This application contains a sequence listing, which has been submitted by EFS-Web and is incorporated herein by reference in its entirety. The ASCII copy created in XX, 20XX is named XXXXXUS_sequencelisting.txt, and the size is X,XXX,XXX bytes. Background technique
[0005] Therapeutic vaccines based on tumor-specific neoantigens have great prospects as the next generation of personalized cancer immunotherapy. 1-3 Considering that the possibility of new antigen production is relatively greater, canc...